Skip to content

Clean it up: How the GMP Draft Annex 1 will impact cleaning and disinfection

Karen Rossington from Contec discusses how a new good manufacturing practice regulation is set to impact cleaning programmes within the pharmaceutical industry.

Clean it up: How the GMP Draft Annex 1 will impact cleaning and disinfection
Published: | 4 min read

Karen Rossington from Contec discusses how a new good manufacturing practice regulation is set to impact cleaning programmes within the pharmaceutical industry. 

Cleanrooms

Cleaning and microbial contamination control are critical focus areas in the pharmaceutical industry. Robust cleaning and disinfection programmes are needed to meet the required cleanroom microbial grades, to prevent cross contamination and microbial contamination of products. Indeed incidents of contaminated products entering the supply chain with devastating consequences have happened in the last eight years.

The manufacture of medicines in the EU is governed by EudraLex Vol 4 Good Manufacturing Practice and each country in Europe takes the legislation into their own guidance.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information